Astrana Health Inc. — Earnings Quality Grade F
ASTH · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 43 days, change -7 days YoY
AR growth 35.7% vs revenue growth 56.4%
Revenue 56.4%, CFFO 119.5%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth 25.8% vs revenue 56.4%. Normal
SG&A/Gross Profit = 63.6%. Normal
Gross margin 10.7%, change -2.6pp. Stable
Cash Flow Quality
CFFO/NI = 5.10. Profits backed by cash
FCF $0.1B, FCF/NI = 4.65
Accruals ratio = -4.2%. Low accruals
Cash $0.4B covers only 40% of debt $1.1B
Balance Sheet Health
Goodwill+Intangibles $1.1B but equity unavailable or non-positive
Debt/EBITDA = 8.0x (>4x). Interest coverage = 1.6x (<2x). Financial stress
Other assets 35.2% vs revenue 56.4%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 2/3 years
Goodwill+Intangibles surged 111% YoY
Manipulation Score
M-Score = -2.15 (grey zone)
Portfolio monitoring
Monitor ASTH continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25